NovaBridge Biosciences annual revenue
2019
2020
2021
2022
2023
2024
2025
NovaBridge Biosciences Revenue Growth & History (NBP)
NovaBridge Biosciences reported $0 in revenue for fiscal 2025.
View full NovaBridge Biosciences company overviewNovaBridge Biosciences annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0 | $0 | — |
| 2024 | 2024-12-31 | $0 | −$632,000 | −100.00% |
| 2023 | 2023-12-31 | $632,000 | $2.2M | +140.75% |
| 2022 | 2022-12-31 | −$1.6M | −$15.4M | −111.23% |
| 2021 | 2021-12-31 | $13.8M | −$222.6M | −94.16% |
| 2020 | 2020-12-31 | $236.4M | $232.1M | +5386.75% |
| 2019 | 2019-12-31 | $4.3M | — | — |
NovaBridge Biosciences quarterly revenue
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $0 | $0 | — |
| Q3 2025 | 2025-09-30 | $0 | — | — |
| Q2 2025 | 2025-06-30 | $0 | — | — |
| Q1 2025 | 2025-03-31 | $0 | — | — |
| Q4 2024 | 2024-12-31 | $0 | — | — |
NovaBridge Biosciences revenue growth trends
NovaBridge Biosciences's latest reported quarter, Q4 2025, generated $0 in revenue.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review NovaBridge Biosciences source filings ↗